Jonathan Smith

1.4k total citations
29 papers, 961 citations indexed

About

Jonathan Smith is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Jonathan Smith has authored 29 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Jonathan Smith's work include Immunotherapy and Immune Responses (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Viral gastroenteritis research and epidemiology (6 papers). Jonathan Smith is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Viral gastroenteritis research and epidemiology (6 papers). Jonathan Smith collaborates with scholars based in United States, Japan and India. Jonathan Smith's co-authors include Peter Berglund, Kurt I. Kamrud, Gary Owens, Bolyn Hubby, H. Kim Lyerly, Michael A. Morse, Amy Hobeika, Takuya Osada, Luis L. Rodrı́guez and Richard S. Lofts and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jonathan Smith

28 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Smith United States	18	459	256	212	201	173	29	961
Debasis Panda United States	21	321 0.7×	376 1.5×	258 1.2×	300 1.5×	133 0.8×	31	1.1k
Luisa Accardi Italy	23	329 0.7×	370 1.4×	356 1.7×	153 0.8×	81 0.5×	45	1.1k
Jason Botten United States	25	1.1k 2.4×	320 1.3×	297 1.4×	320 1.6×	255 1.5×	51	1.6k
Ana da Silva Filipe United Kingdom	17	384 0.8×	436 1.7×	235 1.1×	102 0.5×	139 0.8×	46	1.1k
Sébastien Plumet France	14	600 1.3×	135 0.5×	263 1.2×	183 0.9×	527 3.0×	19	1.0k
Vı́ctor Romanowski Argentina	23	1.1k 2.4×	574 2.2×	256 1.2×	128 0.6×	285 1.6×	79	1.8k
Richard Grant United States	20	637 1.4×	132 0.5×	614 2.9×	206 1.0×	168 1.0×	44	1.4k
Steven A. Kwilas United States	16	448 1.0×	113 0.4×	232 1.1×	109 0.5×	97 0.6×	27	655
Vincent H. J. Léonard United States	15	577 1.3×	186 0.7×	920 4.3×	201 1.0×	123 0.7×	17	1.3k
Takaaki Koma Japan	19	756 1.6×	115 0.4×	202 1.0×	111 0.6×	184 1.1×	63	1.1k

Countries citing papers authored by Jonathan Smith

Since Specialization

Citations

This map shows the geographic impact of Jonathan Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Smith more than expected).

Fields of papers citing papers by Jonathan Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Smith. The network helps show where Jonathan Smith may publish in the future.

Co-authorship network of co-authors of Jonathan Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Smith. A scholar is included among the top collaborators of Jonathan Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Smith. Jonathan Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hurst, Paul J., Maria T. Dulay, Robert M. Waymouth, et al.. (2025). Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery. Journal of Controlled Release. 384. 113944–113944. 2 indexed citations

Matsuda, Kenta, Daisuke Kawakami, Shigeru Suga, et al.. (2024). Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine. iScience. 27(2). 108964–108964. 19 indexed citations

Matsuda, Kenta, Mya Myat Ngwe Tun, Takushi Nomura, et al.. (2024). A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates. Journal of Virology. 98(5). e0023924–e0023924. 14 indexed citations

Morse, Michael A., Erika J. Crosby, Jeremy Force, et al.. (2023). Clinical trials of self-replicating RNA-based cancer vaccines. Cancer Gene Therapy. 30(6). 803–811. 29 indexed citations

Ode, Hirotaka, Tomokazu Tamura, Rigel Suzuki, et al.. (2023). saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nature Communications. 14(1). 2810–2810. 17 indexed citations

Condit, Richard, James S. Robertson, Jean‐Louis Excler, et al.. (2020). The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines. Vaccine. 38(49). 7708–7715. 5 indexed citations

Robertson, James S., Jean‐Louis Excler, Richard Condit, et al.. (2020). The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. Vaccine. 38(34). 5556–5561. 12 indexed citations

Xu, Jing, J. Christopher Luft, Xianwen Yi, et al.. (2013). RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles. Molecular Pharmaceutics. 10(9). 3366–3374. 36 indexed citations

Osada, Takuya, Peter Berglund, Michael A. Morse, et al.. (2012). Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects. Cancer Immunology Immunotherapy. 61(11). 1941–1951. 20 indexed citations

10.

Xu, Jing, Jin Wang, J. Christopher Luft, et al.. (2012). Rendering Protein-Based Particles Transiently Insoluble for Therapeutic Applications. Journal of the American Chemical Society. 134(21). 8774–8777. 58 indexed citations

11.

Kamrud, Kurt I., et al.. (2010). Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. Journal of General Virology. 91(7). 1723–1727. 22 indexed citations

12.

Morse, Michael A., Amy Hobeika, Takuya Osada, et al.. (2010). An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. Journal of Clinical Investigation. 120(9). 3234–3241. 96 indexed citations

13.

Kamrud, Kurt I., Mark Mogler, Alan T. Loynachan, et al.. (2009). Rapid Development of an Efficacious Swine Vaccine for Novel H1N1. PLoS Currents. 1. RRN1123–RRN1123. 24 indexed citations

14.

Reap, Elizabeth A., et al.. (2007). Evaluation of the immunogenicity of an alphavirus replicon particle vaccine expressing the SARS-CoV spike (S) glycoprotein in non-human primates (B191). The Journal of Immunology. 178(1_Supplement). LB40–LB40. 1 indexed citations

15.

Schleiss, Mark R., et al.. (2007). Preconceptual Administration of an Alphavirus Replicon UL83 (pp65 Homolog) Vaccine Induces Humoral and Cellular Immunity and Improves Pregnancy Outcome in the Guinea Pig Model of Congenital Cytomegalovirus Infection. The Journal of Infectious Diseases. 195(6). 789–798. 58 indexed citations

16.

Hubby, Bolyn, Todd Talarico, Maureen F. Maughan, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine. 25(48). 8180–8189. 59 indexed citations

17.

Kamrud, Kurt I., et al.. (2006). Alphavirus replicon approach to promoterless analysis of IRES elements. Virology. 360(2). 376–387. 41 indexed citations

18.

Nishimoto, Kevin, et al.. (2004). A Matter of Life and Death: VEE-Derived Replicon Particle Interactions with the Human Immune System. Journal of Immunotherapy. 27(6). S25–S25. 1 indexed citations

19.

Nelson, Edward L., DaRue A. Prieto, Peter Pushko, et al.. (2003). Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model. Breast Cancer Research and Treatment. 82(3). 169–183. 31 indexed citations

20.

Rodrı́guez, Luis L., Gary O. Maupin, Thomas G. Ksiazek, et al.. (1997). Molecular Investigation of a Multisource Outbreak of Crimeancongo Hemorrhagic Fever in the United Arab Emirates. American Journal of Tropical Medicine and Hygiene. 57(5). 512–518. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact